DE60238633D1 - Screening auf inhibitoren des eindringens von hepatitis-c-virus - Google Patents
Screening auf inhibitoren des eindringens von hepatitis-c-virusInfo
- Publication number
- DE60238633D1 DE60238633D1 DE60238633T DE60238633T DE60238633D1 DE 60238633 D1 DE60238633 D1 DE 60238633D1 DE 60238633 T DE60238633 T DE 60238633T DE 60238633 T DE60238633 T DE 60238633T DE 60238633 D1 DE60238633 D1 DE 60238633D1
- Authority
- DE
- Germany
- Prior art keywords
- screening
- methods
- cell
- hepatitis
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34450401P | 2001-11-09 | 2001-11-09 | |
PCT/EP2002/012272 WO2003040726A2 (en) | 2001-11-09 | 2002-11-01 | Screening for hepatitis c virus entry inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60238633D1 true DE60238633D1 (de) | 2011-01-27 |
Family
ID=23350803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60238633T Expired - Lifetime DE60238633D1 (de) | 2001-11-09 | 2002-11-01 | Screening auf inhibitoren des eindringens von hepatitis-c-virus |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050019751A1 (de) |
EP (1) | EP1444523B1 (de) |
JP (1) | JP2005509160A (de) |
AT (1) | ATE491952T1 (de) |
CA (1) | CA2465731A1 (de) |
DE (1) | DE60238633D1 (de) |
WO (1) | WO2003040726A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0315248D0 (en) * | 2003-06-30 | 2003-08-06 | Hoffmann La Roche | HCV regulated protein expression |
WO2006005465A1 (en) * | 2004-07-08 | 2006-01-19 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
WO2006103493A1 (en) * | 2005-03-29 | 2006-10-05 | Epixis | Methods for enhancing the potency of hcv neutralizing antibodies |
WO2007101710A1 (en) | 2006-03-09 | 2007-09-13 | Cenix Bioscience Gmbh | Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
EP1832283A1 (de) * | 2006-03-09 | 2007-09-12 | Cenix Bioscience GmbH | Verwendung von Inhibitoren der Scavenger Rezeptor Protein Klasse zur Behandlung infektiöser Krankheiten |
WO2008013918A2 (en) * | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
US9052321B2 (en) * | 2008-10-03 | 2015-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Flavivirus-based system for production of hepatitis C virus (HCV) |
EP3374338A1 (de) * | 2015-11-12 | 2018-09-19 | SABIC Global Technologies B.V. | Verfahren zur herstellung von aromaten und olefinen |
CN112121168B (zh) * | 2020-04-09 | 2022-03-04 | 中国人民解放军军事科学院军事医学研究院 | 一种抑制剂在制备治疗SARS-CoV-2肺炎及其并发症的药物中的应用 |
WO2024052379A1 (en) * | 2022-09-07 | 2024-03-14 | United Kingdom Research And Innovation | Therapeutic agents for metabolism-associated diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
US5925333A (en) * | 1995-11-15 | 1999-07-20 | Massachusetts Institute Of Technology | Methods for modulation of lipid uptake |
US5998141A (en) * | 1997-07-10 | 1999-12-07 | Millennium Pharmaceuticals, Inc. | Intronic and polymorphic SR-BI nucleic acids and uses therefor |
-
2002
- 2002-11-01 JP JP2003542928A patent/JP2005509160A/ja not_active Withdrawn
- 2002-11-01 DE DE60238633T patent/DE60238633D1/de not_active Expired - Lifetime
- 2002-11-01 EP EP02802643A patent/EP1444523B1/de not_active Expired - Lifetime
- 2002-11-01 WO PCT/EP2002/012272 patent/WO2003040726A2/en active Application Filing
- 2002-11-01 US US10/494,555 patent/US20050019751A1/en not_active Abandoned
- 2002-11-01 CA CA002465731A patent/CA2465731A1/en not_active Abandoned
- 2002-11-01 AT AT02802643T patent/ATE491952T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003040726A2 (en) | 2003-05-15 |
JP2005509160A (ja) | 2005-04-07 |
EP1444523A2 (de) | 2004-08-11 |
EP1444523B1 (de) | 2010-12-15 |
US20050019751A1 (en) | 2005-01-27 |
ATE491952T1 (de) | 2011-01-15 |
WO2003040726A3 (en) | 2003-12-18 |
CA2465731A1 (en) | 2003-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0511834A (pt) | métodos por tratar hepatite c | |
EA200801025A1 (ru) | Композиция и синтез новых реагентов для ингибирования репликации вич | |
TW200730476A (en) | N-(5-membered aromatic ring)-amido anti-viral compounds | |
EA201000201A1 (ru) | Азотсодержащие бициклические химические вещества для лечения вирусных инфекций | |
ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
NO20044808L (no) | Heterosykliske sulfonamider som er hepatitt C virus inhibitorer | |
CY1113038T1 (el) | Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου | |
UA118080C2 (uk) | Противірусні сполуки | |
EA200701297A1 (ru) | Соединения пиридазинона | |
ATE346035T1 (de) | Inhibitoren von serin proteasen, insbesondere von hepatitis c virus ns3 protease | |
BR0113161A (pt) | Arilóxi piperidinas não imidazóis | |
WO2009069095A3 (en) | Antiviral nucleoside compounds | |
DE60238633D1 (de) | Screening auf inhibitoren des eindringens von hepatitis-c-virus | |
DE602008004317D1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE552347T1 (de) | Oligonukleotidverbindung und verfahren zur behandlung von nidovirusinfektionen | |
WO2005000308A3 (en) | Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c | |
TW200631585A (en) | 5-nitro-nucleoside compounds for treating viral infections | |
ATE316531T1 (de) | Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
DK1893213T3 (da) | Kombination af pyrimidylaminobenzamidforbindelser og imatinib til behandling eller forebyggelse af proliferative sygdomme | |
DE602004004883D1 (de) | Vegf-antagonisten zur behandlung von diabetes | |
EA200401362A1 (ru) | Антивирусная терапия, основанная на противодействии рнк | |
UA90477C2 (ru) | Способ лечения гепатита с (варианты) | |
ATE329308T1 (de) | Laden von software | |
ATE333869T1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R097 | No opposition filed against granted patent, or epo opposition proceedings concluded without decision |
Ref document number: 1444523 Country of ref document: EP Effective date: 20110916 |
|
R082 | Change of representative |
Ref document number: 1444523 Country of ref document: EP Representative=s name: DR. VOLKER VOSSIUS PATENT- UND RECHTSANWALTSKANZLE |